<![CDATA[Biotek-snakken — Oktober 2024]]>Why Viking Therapeutics Stock Topped the Market Today https://proinvestor.com/investornyt/1220817/what-musks-gamble-on-trump-means-for-tesla-stock

]]>https://dev.proinvestor.com/forum/topic/401448/biotek-snakken-oktober-2024RSS for NodeSat, 06 Jun 2026 07:33:00 GMTTue, 01 Oct 2024 02:31:06 GMT60<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Thu, 31 Oct 2024 14:09:22 GMT]]>Det tænker jeg men man ved jo aldrig. GEA udsat til Q2 2025

]]>https://dev.proinvestor.com/forum/post/8067843https://dev.proinvestor.com/forum/post/8067843Thu, 31 Oct 2024 14:09:22 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Thu, 31 Oct 2024 13:09:49 GMT]]>Sukkeralf- regnes den godkendelse ikke værende lige så sikker som amen i kirken? Hvornår er det der ventes nyt vedr GEA ?

]]>https://dev.proinvestor.com/forum/post/8067841https://dev.proinvestor.com/forum/post/8067841Thu, 31 Oct 2024 13:09:49 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Thu, 31 Oct 2024 11:33:17 GMT]]>Lundbeck fremlægger positive fase 3-resultater med migrænemiddel https://proinvestor.com/investornyt/1235691/lundbeck-fremlaegger-positive-fase-3-resultater-med-migraenemiddel

]]>https://dev.proinvestor.com/forum/post/8067840https://dev.proinvestor.com/forum/post/8067840Thu, 31 Oct 2024 11:33:17 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Thu, 31 Oct 2024 08:06:58 GMT]]>Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants

Link Preview Image
NIH VideoCast - Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants

The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (collectively, we) are announcing a public workshop entitled “Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with use of live biotherapeutic products to prevent necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants.

For more information go to https://web.cvent.com/event/7d104839-6b90-4934-aff3-7c273ea4256a/summary

favicon

NIH VideoCast (videocast.nih.gov)

IBT på FDA-workshoppen i USA ..

]]>https://dev.proinvestor.com/forum/post/8067842https://dev.proinvestor.com/forum/post/8067842Thu, 31 Oct 2024 08:06:58 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Wed, 30 Oct 2024 20:41:59 GMT]]>https://ir.zymeworks.com/news-releases/news-release-details/zymeworks-announces-participation-upcoming-investor-19

]]>https://dev.proinvestor.com/forum/post/8067837https://dev.proinvestor.com/forum/post/8067837Wed, 30 Oct 2024 20:41:59 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Wed, 30 Oct 2024 20:41:52 GMT]]>Zymeworks står overfor sin første mulige godkendelse med PDUFA date den 29 november for zanidatamab. De har 6 investorpræsentationer i den kommende tid, så de retter i den grad fokus på sig selv!

]]>https://dev.proinvestor.com/forum/post/8067834https://dev.proinvestor.com/forum/post/8067834Wed, 30 Oct 2024 20:41:52 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Wed, 30 Oct 2024 05:44:43 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8067833https://dev.proinvestor.com/forum/post/8067833Wed, 30 Oct 2024 05:44:43 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Wed, 30 Oct 2024 04:28:22 GMT]]>Biogen And Neomorph Collaborate To Develop Molecular Glue Degraders For Alzheimer's And More https://proinvestor.com/investornyt/1234743/biogen-and-neomorph-collaborate-to-develop-molecular-glue-degraders-for-alzheimers-and-more

]]>https://dev.proinvestor.com/forum/post/8067831https://dev.proinvestor.com/forum/post/8067831Wed, 30 Oct 2024 04:28:22 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Wed, 30 Oct 2024 03:30:39 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8067835https://dev.proinvestor.com/forum/post/8067835Wed, 30 Oct 2024 03:30:39 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Tue, 29 Oct 2024 07:39:14 GMT]]>Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL)™ til voksen brug ved Massachusetts General Hospital

]]>https://dev.proinvestor.com/forum/post/8067839https://dev.proinvestor.com/forum/post/8067839Tue, 29 Oct 2024 07:39:14 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Tue, 29 Oct 2024 05:21:06 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8067832https://dev.proinvestor.com/forum/post/8067832Tue, 29 Oct 2024 05:21:06 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Tue, 29 Oct 2024 04:23:04 GMT]]>AbbVie adds anti-amyloid asset to its CNS repertoire in $1.4B-buyout of Aliada https://firstwordpharma.com/story/5907150

]]>https://dev.proinvestor.com/forum/post/8067829https://dev.proinvestor.com/forum/post/8067829Tue, 29 Oct 2024 04:23:04 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Tue, 29 Oct 2024 04:21:00 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8067826https://dev.proinvestor.com/forum/post/8067826Tue, 29 Oct 2024 04:21:00 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 17:44:05 GMT]]>De begynder at levere!

]]>https://dev.proinvestor.com/forum/post/8067828https://dev.proinvestor.com/forum/post/8067828Mon, 28 Oct 2024 17:44:05 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 15:23:33 GMT]]>Bioporto indgår aftale med Beckman Coulter om distribution https://proinvestor.com/investornyt/1233817/bioporto-indgar-aftale-med-beckman-coulter-om-distribution

]]>https://dev.proinvestor.com/forum/post/8067838https://dev.proinvestor.com/forum/post/8067838Mon, 28 Oct 2024 15:23:33 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 12:43:41 GMT]]>Altid svært at sammenligne aftaler, når man ikke kender ret mange detaljer - 2,1 milliard dollars i milestonebetalinger nok det mest prangende, men sikkert på bekostning andre steder. Men men men degraders fylder stille og roligt mere og mere i landskabet.

]]>https://dev.proinvestor.com/forum/post/8067825https://dev.proinvestor.com/forum/post/8067825Mon, 28 Oct 2024 12:43:41 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 12:41:19 GMT]]>https://ir.monterosatx.com/news-releases/news-release-details/monte-rosa-therapeutics-announces-global-license-agreement

]]>https://dev.proinvestor.com/forum/post/8067823https://dev.proinvestor.com/forum/post/8067823Mon, 28 Oct 2024 12:41:19 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 12:41:15 GMT]]>Flot glue degrader aftale af Monte Rosa Therapeutics med Novartis på et ret ukendt target.

]]>https://dev.proinvestor.com/forum/post/8067827https://dev.proinvestor.com/forum/post/8067827Mon, 28 Oct 2024 12:41:15 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 08:58:16 GMT]]>AlzeCure presents new positive data for the TrkA-NAM pain project against osteoarthritis https://storage.mfn.se/67262b49-af19-46f1-892a-84f1a7b0d86e/alzecure-presents-new-positive-data-for-the-trka-nam-pain-project-against-osteoarthritis.pdf

]]>https://dev.proinvestor.com/forum/post/8067824https://dev.proinvestor.com/forum/post/8067824Mon, 28 Oct 2024 08:58:16 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 05:35:16 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8067820https://dev.proinvestor.com/forum/post/8067820Mon, 28 Oct 2024 05:35:16 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Mon, 28 Oct 2024 04:08:23 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8067822https://dev.proinvestor.com/forum/post/8067822Mon, 28 Oct 2024 04:08:23 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Sat, 26 Oct 2024 09:52:36 GMT]]>The Ultimate Biotech Stock to Buy With $50 Right Now https://proinvestor.com/investornyt/1233181/the-ultimate-biotech-stock-to-buy-with-50-right-now

]]>https://dev.proinvestor.com/forum/post/8067817https://dev.proinvestor.com/forum/post/8067817Sat, 26 Oct 2024 09:52:36 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Thu, 24 Oct 2024 08:12:16 GMT]]>Selskabspræsentation: Mød Cessatech på tirsdag.

Webinarinfo

Dato:

29.10.2024

Tid:

16:00

Sted:

Online https://www.nordnet.dk/events/selskabspraesentation-cessatech?utm_source=ACS&utm_medium=email&utm_campaign=DK_webinar_cessatech_241024

]]>https://dev.proinvestor.com/forum/post/8067830https://dev.proinvestor.com/forum/post/8067830Thu, 24 Oct 2024 08:12:16 GMT<![CDATA[Reply to Biotek-snakken — Oktober 2024 on Thu, 24 Oct 2024 03:45:54 GMT]]>Ascelia Pharma presenterar Late Breaking Abstract av SPARKLE-data vid American Society of Nephrology Kidney Week Congress 2024

Link Preview Image
Ascelia Pharma Presents Late-Breaking Abstract on SPARKLE Data at the American Society of Nephrology Kidney Week Congress 2024 – ASCELIA

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announce ...

favicon

(www.ascelia.com)

.. The presentation will be held on October 24, 2024, from 10:00 AM to 12:00 PM, and will be part of the Late-Breaking Science Posters session. ..

]]>https://dev.proinvestor.com/forum/post/8067836https://dev.proinvestor.com/forum/post/8067836Thu, 24 Oct 2024 03:45:54 GMT